Mosaic ImmunoEngineering (OTCMKTS:CPMV) Announces Quarterly Earnings Results

Mosaic ImmunoEngineering (OTCMKTS:CPMV) posted its quarterly earnings data on Wednesday. The company reported ($0.02) EPS for the quarter, Zacks reports.

Mosaic ImmunoEngineering Price Performance

Shares of Mosaic ImmunoEngineering stock remained flat at $0.60 during mid-day trading on Wednesday. 3 shares of the company’s stock traded hands, compared to its average volume of 1,267. The company has a market cap of $4.35 million, a PE ratio of -6.00 and a beta of -1.04. Mosaic ImmunoEngineering has a one year low of $0.25 and a one year high of $1.05. The stock has a fifty day moving average of $0.67 and a 200-day moving average of $0.54.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.